132 related articles for article (PubMed ID: 38282338)
1. Improving cancer stem cells killing in malignant melanoma.
Bergamaschi D
Br J Dermatol; 2024 Apr; 190(5):615-616. PubMed ID: 38282338
[No Abstract] [Full Text] [Related]
2. Embryonic Stem Cells Modulate the Cancer-Permissive Microenvironment of Human Uveal Melanoma.
Liu J; Huang Z; Yang L; Wang X; Wang S; Li C; Liu Y; Cheng Y; Wang B; Sang X; He X; Wang C; Liu T; Liu C; Jin L; Liu C; Zhang X; Wang L; Wang Z
Theranostics; 2019; 9(16):4764-4778. PubMed ID: 31367256
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma: diagnosis, treatment and cancer stem cells.
Kozovska Z; Gabrisova V; Kucerova L
Neoplasma; 2016; 63(4):510-7. PubMed ID: 27268913
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells and human malignant melanoma.
Schatton T; Frank MH
Pigment Cell Melanoma Res; 2008 Feb; 21(1):39-55. PubMed ID: 18353142
[TBL] [Abstract][Full Text] [Related]
5. Enhanced melanoma cell-killing by combined phototherapy/radiotherapy using a mesoporous platinum nanostructure.
Salehi F; Daneshvar F; Karimi M; Dehdari Vais R; Mosleh-Shirazi MA; Sattarahmady N
Photodiagnosis Photodyn Ther; 2019 Dec; 28():300-307. PubMed ID: 31606514
[TBL] [Abstract][Full Text] [Related]
6. The killing effect of 4-S-cysteaminylphenol, a newly synthesised melanin precursor, on B16 melanoma cell lines.
Yamada I; Seki S; Ito S; Suzuki S; Matsubara O; Kasuga T
Br J Cancer; 1991 Feb; 63(2):187-90. PubMed ID: 1997095
[TBL] [Abstract][Full Text] [Related]
7. Melanoma stem cell vaccine induces effective tumor immunity against melanoma.
Yin Q; Zhao N; Chang Y; Dong M; Xu M; Xu W; Jin HF; Liu W; Xu N
Hum Vaccin Immunother; 2023 Dec; 19(1):2158670. PubMed ID: 37067182
[TBL] [Abstract][Full Text] [Related]
8. Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy model.
Helfand SC; Soergel SA; Donner RL; Gan J; Hank JA; Lindstrom MJ; Sondel PM
J Immunother Emphasis Tumor Immunol; 1994 Oct; 16(3):188-97. PubMed ID: 7834118
[TBL] [Abstract][Full Text] [Related]
9. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
10. Potential function of CTLA-4 in the tumourigenic capacity of melanoma stem cells.
Zhang B; Dang J; Ba D; Wang C; Han J; Zheng F
Oncol Lett; 2018 Nov; 16(5):6163-6170. PubMed ID: 30344757
[TBL] [Abstract][Full Text] [Related]
11. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
[TBL] [Abstract][Full Text] [Related]
12. Identification of Cancer Stem Cell Subpopulations in Head and Neck Metastatic Malignant Melanoma.
Yoganandarajah V; Patel J; van Schaijik B; Bockett N; Brasch HD; Paterson E; Sim D; Davis PF; Roth IM; Itinteang T; Tan ST
Cells; 2020 Jan; 9(2):. PubMed ID: 32019273
[TBL] [Abstract][Full Text] [Related]
13. Research Progress of Cancer Stem Cells in Uveal Melanoma.
Chen YN; Li Y; Wei WB
Onco Targets Ther; 2020; 13():12243-12252. PubMed ID: 33273829
[TBL] [Abstract][Full Text] [Related]
14. Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses.
Vollmers EM; Tattersall P
Virology; 2013 Nov; 446(1-2):37-48. PubMed ID: 24074565
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of CYP2E1 recombinant adenovirus to malignant melanoma by bone marrow-derived mesenchymal stem cells as vehicles.
Wang J; Ma D; Li Y; Yang Y; Hu X; Zhang W; Fang Q
Anticancer Drugs; 2014 Mar; 25(3):303-14. PubMed ID: 24413391
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells, epigenetics, tumor microenvironment and future therapeutics in cutaneous malignant melanoma: a review.
Kyriakou G; Melachrinou M
Future Oncol; 2020 Jul; 16(21):1549-1567. PubMed ID: 32484008
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis.
Al Dhaybi R; Sartelet H; Powell J; Kokta V
Mod Pathol; 2010 Mar; 23(3):376-80. PubMed ID: 20062010
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and injuries of heavy ion beam and x-ray radiation on malignant melanoma cell.
Qin J; Li S; Zhang C; Gao DW; Li Q; Zhang H; Jin XD; Liu Y
Exp Biol Med (Maywood); 2017 May; 242(9):953-960. PubMed ID: 28133985
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma.
Palacios-Ferrer JL; García-Ortega MB; Gallardo-Gómez M; García MÁ; Díaz C; Boulaiz H; Valdivia J; Jurado JM; Almazan-Fernandez FM; Arias-Santiago S; Amezcua V; Peinado H; Vicente F; Pérez Del Palacio J; Marchal JA
Mol Oncol; 2021 Feb; 15(2):407-428. PubMed ID: 33052601
[TBL] [Abstract][Full Text] [Related]
20. [Valproate up-regulates the expression of NKG2DL through the MEK/ERK signaling pathway to enhance the killing effect of NK cells on A375 human melanoma cells].
Li S; Wang Y; Yan H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Jan; 38(1):32-38. PubMed ID: 35078573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
